Hepatitis C viraemia in HIV–HCV co-infected patients having immune restoration with highly active antiretroviral therapy
- 1 January 2000
- journal article
- research article
- Published by Wolters Kluwer Health in AIDS
- Vol. 14 (2) , 212
- https://doi.org/10.1097/00002030-200001280-00023
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Sustained Disappearance of Hepatitis C Viremia in Patients Receiving Protease Inhibitor Treatment for Human Immunodeficiency Virus InfectionThe Journal of Infectious Diseases, 1999
- Management of chronic hepatitis C in HIV-infected patientsAIDS, 1999
- Impact of chronic liver disease due to hepatitis viruses as cause of hospital admission and death in HIV-infected drug usersEuropean Journal of Epidemiology, 1999
- Hepatotoxicity after introduction of highly active antiretroviral therapyAIDS, 1998
- Lack of benefit or protease inhibitors on HCV viremia in HIV- infected patientsJournal of Hepatology, 1998
- Impact of treatment with human immunodeficiency virus (HIV) protease inhibitors on hepatitis C viremia in patients coinfected with HIV.The Journal of Infectious Diseases, 1998
- Branched DNA Signal Amplification for Direct Quantitation of Nucleic Acid Sequences in Clinical SpecimensPublished by Elsevier ,1998
- A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or LessNew England Journal of Medicine, 1997
- Influence of human immunodeficiency virus type 1 infection on the natural course of chronic parenterally acquired Hepatitis CEuropean Journal of Clinical Microbiology & Infectious Diseases, 1995
- Correlates of Hepatitis C Virus Infections among Injection Drug UsersMedicine, 1995